Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Merck & Co. divulges new hSTING agonists

June 26, 2020

Onxeo reports preclinical data for its new generation molecule, OX-401

June 26, 2020

New way to target drugs, independently of drug target

June 26, 2020

AACR Virtual Meeting II: Combination therapies: Searching for synergy

June 25, 2020

Hangzhou Innogate Pharma presents new CDK and HDAC dual inhibitors

June 25, 2020

Merck KGaA divulges new tankyrase inhibitors

June 25, 2020

SIK3 inhibitor OMX-0370 shows promising antitumor activity

June 25, 2020

FDA grants accelerated approval to Xpovio for relapsed or refractory DLBCL

June 23, 2020

First-in-human study of in vivo imaging with Cu-64 SPION

June 23, 2020

First patient dosed in phase Ib study of nirogacestat plus belantamab mafodotin in multiple myeloma

June 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...